Mark Holliday

27 papers receiving 1.1k citations

Mark Holliday's Hit Papers

Controlled Trial of Budesonide–Formoterol as Needed for Mild Asthma 2019 · 349 citations
3490+2+4Years since publication100200300

Peers

Mark Holliday
Comparison fields: 5 of 79
  • Physiology 872
  • Critical Care and Intensive Care Medicine 81
  • Family Practice 21
  • Pulmonary and Respiratory Medicine 86
  • Epidemiology 64
Replace James Fingleton with:
James Fingleton New Zealand
Stefano G. Nardini Italy
Dominic S. Chalut Canada
Jesse C. Theisen-Toupal United States
Dhenuka Radhakrishnan Canada
Nick P Adams United Kingdom
Morgan Jaffrelot France
Charles F. A. Pantin United Kingdom
Akaki Lekiachvili United States
Robert I. Docking United Kingdom
Mark Holliday relative to James Fingleton New Zealand James Fingleton's profile →
Citations per field
00.5×5×11.6×
James Fingleton · 1×
Citations per year

Countries citing papers authored by Mark Holliday

Since Specialization
Citations

This map shows the geographic impact of Mark Holliday's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Holliday with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Holliday more than expected).

Fields of papers citing papers by Mark Holliday

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Holliday. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Holliday. The network helps show where Mark Holliday may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Holliday, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Holliday Line = papers co-authored together Mark Holliday links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Controlled Trial of Budesonide–Formoterol as Needed for Mild Asthma
Hit paper breakdown →
2019349
2 2019221
3 2015170
4 2020101
5 202052
6 201640
7 202034
8 201529
9 201623
10 202120
11 202420
12 201717
13 202016
14 202016
15 202113
16 201712
17 202211
18 20208
19 20208
20 20247

About Mark Holliday

Mark Holliday is a scholar working on Physiology, Critical Care and Intensive Care Medicine, Modeling and Simulation, Dermatology and Pulmonary and Respiratory Medicine, having authored 28 papers that have together received 1.2k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (25 papers), Inhalation and Respiratory Drug Delivery (2 papers), Health Systems, Economic Evaluations, Quality of Life (1 paper), Thermal Regulation in Medicine (1 paper), Sepsis Diagnosis and Treatment (1 paper), COVID-19 epidemiological studies (1 paper), Environmental Impact and Sustainability (1 paper) and Acne and Rosacea Treatments and Effects (1 paper). The work is most often cited by research in Physiology (872 citations), Critical Care and Intensive Care Medicine (81 citations), Family Practice (21 citations), Pulmonary and Respiratory Medicine (86 citations) and Epidemiology (64 citations). Mark Holliday has collaborated with scholars based in New Zealand, United Kingdom and Australia. Frequent co-authors include Richard W. Beasley, Mark W Weatherall, Irene E. Braithwaite, Helen Kathryn Reddel, Robert John Hancox, Ian Douglas Pavord, Tim W Harrison, Stefan Ebmeier, Alberto A. Papi and Mathew Williams. Their work appears in journals such as ERJ Open Research, European Respiratory Journal, BMJ Open, BMJ Open Respiratory Research and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact